Author

Baptiste Simon

ORCID 0009-0009-6840-0530Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:deep learning· 2 Organism:human· 2 Assay:scRNA-seq· 2 Assay:ChIP-seq· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Approach:statistical model· 1

Frequent Co-Authors

Amélie RoehrigiD· 2 shared Céline VallotiD· 2 shared Juliette BertorelloiD· 2 shared Adeline DurandiD· 1 shared Agathe Kahn· 1 shared Amanda PupoiD· 1 shared Anne Vincent‐SalomoniD· 1 shared Christophe Le TourneauiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Amélie RoehrigORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJul 28, 2026

Routine FFPE sections support clinically compatible single-nucleus transcriptomics across six human cancer types

Jasper Wouters, Juliette Bertorello, Marine Gaillard…·Céline Vallot

This paper develops a workflow for single-nucleus transcriptomics from FFPE tumor samples, showing reproducible cellular composition analysis across six cancer types.

DOI 10.64898/2026.07.23.740343

humanscRNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintDec 8, 2025

A single-nucleus multimodal framework reveals epigenomic priming of chemoresistant states in ovarian cancer

Yuna Landais, Juliette Bertorello, Marta Puerto…·Céline Vallot

This paper develops a single-nucleus multimodal framework to analyze transcriptional and histone modification landscapes in ovarian cancer, revealing epigenomic priming of chemoresistant states and its impact on treatment outcomes.

DOI 10.64898/2025.12.04.692102

humanscRNA-seq

𝕏 PostBluesky